Biotech–biotech company mergers puzzle investors

被引：0

|

作者：

Emma Dorey

机构：

来源：

Nature Biotechnology | 1998年 / 16卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：616 / 616

相关论文

共 50 条

[31] Dow banks on biotech for company growth
Thayer, A
CHEMICAL & ENGINEERING NEWS, 1998, 76 (37) : 9 - 9
[32] BIOTECH INVESTOR FORMS NEW COMPANY
不详
CHEMICAL & ENGINEERING NEWS, 2008, 86 (46) : 27 - 27
[33] Biotech is back - Strong financial markets and educated investors are making biotech stronger than ever
Burrill, GS
BIOPHARM-THE TECHNOLOGY & BUSINESS OF BIOPHARMACEUTICALS, 1995, 8 (09): : 48 - 50
[34] AG BIOTECH FIRMS LAG IN REGAINING INVESTORS FAVOR
FINN, R
SCIENTIST, 1995, 9 (18): : 1 - &
[35] Biotech company issues along the value chain
Burrill, GS
BIOPHARM-THE TECHNOLOGY & BUSINESS OF BIOPHARMACEUTICALS, 1996, 9 (04): : 24 - &
[36] Vivalis and Intercell to Create New Biotech Company
Sutton, Stephanie
BIOPHARM INTERNATIONAL, 2013, 26 (01) : 8 - 8
[37] On step in Sup'Biotech, the other already in the company
Wierzbicki, Julie
BIOFUTUR, 2006, (272) : 56 - 57
[38] US company secures QLD biotech discovery
Dales, J
AUSTRALASIAN BIOTECHNOLOGY, 2000, 10 (03) : 13 - 13
[39] Slovakia - Degussa buys out biotech company
Alperowicz, A
CHEMICAL WEEK, 1998, 160 (43) : 21 - 21
[40] A BIOTECH COMPANY PERSPECTIVE ON LICENSING BIOTECHNOLOGY INVENTIONS
HENSLEY, MD
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1992, 203 : 11 - BTEC

← 1 2 3 4 5 →